Performance of Previously Identified Predictors of >=15% Body Weight Reduction with Tirzepatide in Participants with Type 2 Diabetes in SURMOUNT-2

被引：0
|
作者：
Lingvay, Ildiko
Malecki, Maciej
Benabbad, Imane
Falcon, Beverly
Lee, Clare
Wang, Hui
Dunn, Julia P.
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-815-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
815-P
引用
收藏
页数：3
相关论文
共 50 条
  • [31] TIRZEPATIDE AND WEIGHT REDUCTION AMONG INDIVIDUALS WITHOUT EVIDENCE OF TYPE 2 DIABETES: DESCRIPTIVE RESULTS FROM OPTUM'S DE-IDENTIFIED MARKET CLARITY DATA
    Hunter, T.
    Hankosky, E. R.
    Meeks, A. C.
    Ward, J.
    Chinthammit, C.
    VALUE IN HEALTH, 2024, 27 (06) : S387 - S387
  • [32] Tirzepatide Reduces the Predicted Risk of Developing Type 2 Diabetes-Post Hoc Analysis of the SURMOUNT-1 Trial
    Hankosky, Emily R.
    Wang, Hui
    Neff, Lisa M.
    Kan, Hongjun
    Wang, Fangyu
    Ahmad, Nadia
    Garvey, W. Timothy
    DIABETES, 2023, 72
  • [33] A phase 1 multiple-ascending dose study of tirzepatide in Japanese participants with type 2 diabetes
    Furihata, Kenichi
    Mimura, Hanaka
    Urva, Shweta
    Oura, Tomonori
    Ohwaki, Kenji
    Imaoka, Takeshi
    DIABETES OBESITY & METABOLISM, 2022, 24 (02): : 239 - 246
  • [34] Body Weight Considerations in the Management of Type 2 Diabetes
    Apovian, Caroline M.
    Okemah, Jennifer
    O'Neil, Patrick M.
    ADVANCES IN THERAPY, 2019, 36 (01) : 44 - 58
  • [35] SURMOUNTing body weight barriers in type 2 diabetes
    Novikoff, Aaron
    Mueller, Timo D.
    MED, 2023, 4 (12): : 849 - 851
  • [36] Body Weight Considerations in the Management of Type 2 Diabetes
    Caroline M. Apovian
    Jennifer Okemah
    Patrick M. O’Neil
    Advances in Therapy, 2019, 36 : 44 - 58
  • [37] Obesity/Type 2 diabetes: GLP-1 agonist tirzepatide promotes weight loss
    Simon, Annika
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (08) : 416 - 416
  • [38] Tirzepatide-induced weight loss in type 2 diabetes is independent of nausea, vomiting, or diarrhoea
    Patel, H.
    Khunti, K.
    Rodbard, H. W.
    Bajaj, H. S.
    Bray, R.
    Kindracki, Z.
    Rodriguez, A.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S290 - S291
  • [39] Obesity/Type 2 diabetes: GLP-1 agonist tirzepatide promotes weight loss
    Simon, Annika
    DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 (01) : 27 - 28
  • [40] Tirzepatide reduces the predicted risk of developing type 2 diabetes in people with obesity or overweight: Post hoc analysis of the SURMOUNT-1 trial
    Hankosky, Emily R.
    Wang, Hui
    Neff, Lisa M.
    Kan, Hong
    Wang, Fangyu
    Ahmad, Nadia N.
    Stefanski, Adam
    Garvey, W. Timothy
    DIABETES OBESITY & METABOLISM, 2023, 25 (12): : 3748 - 3756
12345